The antiretroviral drug dapivirine contained in a vaginal ring for HIV prevention, is absorbed in very low concentrations into breastmilk, according to a study of the dapivirine ring in women who were no longer nursing their babies but still producing milk. Researchers are now planning studies of the ring in African women who are breastfeeding as well as during pregnancy, when there may be a greater risk of acquiring HIV.